Device Trial Radar · NCT07209098
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Last checked: Nov 19, 2026Latest source record: Mar 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
4,200
Planned (sponsor's estimate)
Start
Nov 18, 2025
Primary completion
Oct 2030
Study completion Apr 2031
Sponsor
- Lead sponsor
- Impulse DynamicsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 6, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this prospective, multi-center, propensity-matched coverage with evidence development (CED) study is to assess the impact of cardiac contractility modulation (CCM) on mortality and heart failure hospitalizations in Medicare-eligible patients with heart failure who meet indications for CCM.
Conditions
- Heart Failure and Reduced Ejection Fraction
- NYHA Class III Heart Failure
Interventions
Cardiac Contractility Modulation (CCM)Device
CCM is a therapy delivered via the Optimizer System, which is implanted in eligible heart failure patients. The device delivers non-excitatory electrical signals to the heart during the absolute refractory period, enhancing the strength of cardiac contractions without increasing myocardial oxygen consumption.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first heart failure hospitalization or all-cause deathTime frame: Up to 2 years post-index date for each patient; follow-up will continue until 2 years after the last patient is enrolled to allow at least 2 years of observation for all participants.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Impulse Dynamics
Marlton, New Jersey · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.